HEADER TRANSPORT PROTEIN 30-OCT-08 3F3E TITLE CRYSTAL STRUCTURE OF LEUT BOUND TO L-LEUCINE (30 MM) AND SODIUM CAVEAT 3F3E BOG A 706 HAS WRONG CHIRALITY AT ATOM C1 BOG A 706 HAS WRONG CAVEAT 2 3F3E CHIRALITY AT ATOM C2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRANSPORTER; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: LEUCINE TRANSPORTER; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: AQUIFEX AEOLICUS; SOURCE 3 ORGANISM_TAXID: 63363; SOURCE 4 STRAIN: VF5; SOURCE 5 GENE: SNF, AQ_2077; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: C41(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET16B KEYWDS SLC6, NSS, TRANSMEMBRANE, SODIUM-COUPLED, TRANSPORTER, SYMPORT, KEYWDS 2 TRANSPORT, TRANSPORT PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR S.K.SINGH,C.L.PISCITELLI,A.YAMASHITA,E.GOUAUX REVDAT 5 06-SEP-23 3F3E 1 HETSYN REVDAT 4 29-JUL-20 3F3E 1 CAVEAT COMPND REMARK SEQADV REVDAT 4 2 1 HETNAM SITE REVDAT 3 24-JUL-19 3F3E 1 REMARK REVDAT 2 10-MAR-09 3F3E 1 JRNL REVDAT 1 23-DEC-08 3F3E 0 JRNL AUTH S.K.SINGH,C.L.PISCITELLI,A.YAMASHITA,E.GOUAUX JRNL TITL A COMPETITIVE INHIBITOR TRAPS LEUT IN AN OPEN-TO-OUT JRNL TITL 2 CONFORMATION. JRNL REF SCIENCE V. 322 1655 2008 JRNL REFN ISSN 0036-8075 JRNL PMID 19074341 JRNL DOI 10.1126/SCIENCE.1166777 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.44 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 56694 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.181 REMARK 3 R VALUE (WORKING SET) : 0.180 REMARK 3 FREE R VALUE : 0.205 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.070 REMARK 3 FREE R VALUE TEST SET COUNT : 2877 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 44.4538 - 4.9562 0.98 2617 148 0.2035 0.2176 REMARK 3 2 4.9562 - 3.9347 1.00 2610 139 0.1737 0.1744 REMARK 3 3 3.9347 - 3.4375 1.00 2604 146 0.1656 0.1922 REMARK 3 4 3.4375 - 3.1233 1.00 2600 131 0.1737 0.1906 REMARK 3 5 3.1233 - 2.8995 1.00 2620 135 0.1731 0.2081 REMARK 3 6 2.8995 - 2.7286 1.00 2583 134 0.1688 0.2156 REMARK 3 7 2.7286 - 2.5919 0.99 2561 136 0.1654 0.2279 REMARK 3 8 2.5919 - 2.4791 0.99 2570 149 0.1641 0.1837 REMARK 3 9 2.4791 - 2.3837 0.99 2595 124 0.1574 0.1760 REMARK 3 10 2.3837 - 2.3014 0.99 2546 155 0.1585 0.1845 REMARK 3 11 2.3014 - 2.2295 0.99 2544 145 0.1611 0.2134 REMARK 3 12 2.2295 - 2.1657 0.99 2594 115 0.1627 0.2115 REMARK 3 13 2.1657 - 2.1087 0.99 2578 138 0.1600 0.2203 REMARK 3 14 2.1087 - 2.0573 0.99 2562 129 0.1696 0.2086 REMARK 3 15 2.0573 - 2.0105 0.99 2528 128 0.1726 0.2019 REMARK 3 16 2.0105 - 1.9677 0.99 2549 145 0.1812 0.2058 REMARK 3 17 1.9677 - 1.9284 0.98 2539 131 0.1925 0.2221 REMARK 3 18 1.9284 - 1.8920 0.98 2535 130 0.2038 0.2620 REMARK 3 19 1.8920 - 1.8582 0.98 2562 133 0.2060 0.2553 REMARK 3 20 1.8582 - 1.8267 0.98 2493 138 0.2227 0.2607 REMARK 3 21 1.8267 - 1.8000 0.93 2427 148 0.2461 0.2732 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.36 REMARK 3 B_SOL : 80.21 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.220 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 27.04 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.56 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.011 NULL REMARK 3 ANGLE : 1.244 NULL REMARK 3 CHIRALITY : 0.084 NULL REMARK 3 PLANARITY : 0.006 NULL REMARK 3 DIHEDRAL : 17.273 NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3F3E COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-NOV-08. REMARK 100 THE DEPOSITION ID IS D_1000050096. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-JUL-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.2.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 56738 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 7.300 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 34.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.1 REMARK 200 DATA REDUNDANCY IN SHELL : 6.80 REMARK 200 R MERGE FOR SHELL (I) : 0.75000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 2A65 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.42 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES, 0.2M NACL, 17-22% PEG-MME REMARK 280 550, PH 7.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 44.68050 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.33200 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 44.68050 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 43.33200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7960 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 38640 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 80.93903 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 80.94504 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 618 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLU A 2 REMARK 465 VAL A 3 REMARK 465 LYS A 4 REMARK 465 ASN A 133 REMARK 465 ALA A 134 REMARK 465 LEU A 516 REMARK 465 VAL A 517 REMARK 465 PRO A 518 REMARK 465 ARG A 519 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O ILE A 106 O HOH A 603 2.04 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 54 -53.25 -129.26 REMARK 500 PRO A 160 47.62 -84.68 REMARK 500 ILE A 297 -74.84 -92.75 REMARK 500 ILE A 325 -58.78 -121.59 REMARK 500 THR A 409 -73.39 -121.43 REMARK 500 TYR A 471 -52.13 -148.83 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 BOG A 707 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2A65 RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH L-LEUCINE AND SODIUM REMARK 900 RELATED ID: 2QEI RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH L-ALANINE, SODIUM, AND CLOMIPRAMINE REMARK 900 RELATED ID: 3F3A RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF LEUT BOUND TO L-TRYPTOPHAN AND SODIUM REMARK 900 RELATED ID: 3F3C RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF LEUT BOUND TO 4-FLUORO-L-PHENYLALANINE AND REMARK 900 SODIUM REMARK 900 RELATED ID: 3F3D RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF LEUT BOUND TO L-METHIONINE AND SODIUM REMARK 900 RELATED ID: 3F48 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF LEUT BOUND TO L-ALANINE AND SODIUM REMARK 900 RELATED ID: 3F4I RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF LEUT BOUND TO L-SELENOMETHIONINE AND SODIUM REMARK 900 RELATED ID: 3F4J RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF LEUT BOUND TO GLYCINE AND SODIUM DBREF 3F3E A 1 513 UNP O67854 O67854_AQUAE 1 513 SEQADV 3F3E GLY A 514 UNP O67854 EXPRESSION TAG SEQADV 3F3E THR A 515 UNP O67854 EXPRESSION TAG SEQADV 3F3E LEU A 516 UNP O67854 EXPRESSION TAG SEQADV 3F3E VAL A 517 UNP O67854 EXPRESSION TAG SEQADV 3F3E PRO A 518 UNP O67854 EXPRESSION TAG SEQADV 3F3E ARG A 519 UNP O67854 EXPRESSION TAG SEQRES 1 A 519 MET GLU VAL LYS ARG GLU HIS TRP ALA THR ARG LEU GLY SEQRES 2 A 519 LEU ILE LEU ALA MET ALA GLY ASN ALA VAL GLY LEU GLY SEQRES 3 A 519 ASN PHE LEU ARG PHE PRO VAL GLN ALA ALA GLU ASN GLY SEQRES 4 A 519 GLY GLY ALA PHE MET ILE PRO TYR ILE ILE ALA PHE LEU SEQRES 5 A 519 LEU VAL GLY ILE PRO LEU MET TRP ILE GLU TRP ALA MET SEQRES 6 A 519 GLY ARG TYR GLY GLY ALA GLN GLY HIS GLY THR THR PRO SEQRES 7 A 519 ALA ILE PHE TYR LEU LEU TRP ARG ASN ARG PHE ALA LYS SEQRES 8 A 519 ILE LEU GLY VAL PHE GLY LEU TRP ILE PRO LEU VAL VAL SEQRES 9 A 519 ALA ILE TYR TYR VAL TYR ILE GLU SER TRP THR LEU GLY SEQRES 10 A 519 PHE ALA ILE LYS PHE LEU VAL GLY LEU VAL PRO GLU PRO SEQRES 11 A 519 PRO PRO ASN ALA THR ASP PRO ASP SER ILE LEU ARG PRO SEQRES 12 A 519 PHE LYS GLU PHE LEU TYR SER TYR ILE GLY VAL PRO LYS SEQRES 13 A 519 GLY ASP GLU PRO ILE LEU LYS PRO SER LEU PHE ALA TYR SEQRES 14 A 519 ILE VAL PHE LEU ILE THR MET PHE ILE ASN VAL SER ILE SEQRES 15 A 519 LEU ILE ARG GLY ILE SER LYS GLY ILE GLU ARG PHE ALA SEQRES 16 A 519 LYS ILE ALA MET PRO THR LEU PHE ILE LEU ALA VAL PHE SEQRES 17 A 519 LEU VAL ILE ARG VAL PHE LEU LEU GLU THR PRO ASN GLY SEQRES 18 A 519 THR ALA ALA ASP GLY LEU ASN PHE LEU TRP THR PRO ASP SEQRES 19 A 519 PHE GLU LYS LEU LYS ASP PRO GLY VAL TRP ILE ALA ALA SEQRES 20 A 519 VAL GLY GLN ILE PHE PHE THR LEU SER LEU GLY PHE GLY SEQRES 21 A 519 ALA ILE ILE THR TYR ALA SER TYR VAL ARG LYS ASP GLN SEQRES 22 A 519 ASP ILE VAL LEU SER GLY LEU THR ALA ALA THR LEU ASN SEQRES 23 A 519 GLU LYS ALA GLU VAL ILE LEU GLY GLY SER ILE SER ILE SEQRES 24 A 519 PRO ALA ALA VAL ALA PHE PHE GLY VAL ALA ASN ALA VAL SEQRES 25 A 519 ALA ILE ALA LYS ALA GLY ALA PHE ASN LEU GLY PHE ILE SEQRES 26 A 519 THR LEU PRO ALA ILE PHE SER GLN THR ALA GLY GLY THR SEQRES 27 A 519 PHE LEU GLY PHE LEU TRP PHE PHE LEU LEU PHE PHE ALA SEQRES 28 A 519 GLY LEU THR SER SER ILE ALA ILE MET GLN PRO MET ILE SEQRES 29 A 519 ALA PHE LEU GLU ASP GLU LEU LYS LEU SER ARG LYS HIS SEQRES 30 A 519 ALA VAL LEU TRP THR ALA ALA ILE VAL PHE PHE SER ALA SEQRES 31 A 519 HIS LEU VAL MET PHE LEU ASN LYS SER LEU ASP GLU MET SEQRES 32 A 519 ASP PHE TRP ALA GLY THR ILE GLY VAL VAL PHE PHE GLY SEQRES 33 A 519 LEU THR GLU LEU ILE ILE PHE PHE TRP ILE PHE GLY ALA SEQRES 34 A 519 ASP LYS ALA TRP GLU GLU ILE ASN ARG GLY GLY ILE ILE SEQRES 35 A 519 LYS VAL PRO ARG ILE TYR TYR TYR VAL MET ARG TYR ILE SEQRES 36 A 519 THR PRO ALA PHE LEU ALA VAL LEU LEU VAL VAL TRP ALA SEQRES 37 A 519 ARG GLU TYR ILE PRO LYS ILE MET GLU GLU THR HIS TRP SEQRES 38 A 519 THR VAL TRP ILE THR ARG PHE TYR ILE ILE GLY LEU PHE SEQRES 39 A 519 LEU PHE LEU THR PHE LEU VAL PHE LEU ALA GLU ARG ARG SEQRES 40 A 519 ARG ASN HIS GLU SER ALA GLY THR LEU VAL PRO ARG HET LEU A 601 9 HET BOG A 701 20 HET BOG A 702 20 HET BOG A 703 20 HET BOG A 704 20 HET BOG A 705 20 HET BOG A 706 20 HET BOG A 707 14 HET NA A 751 1 HET NA A 752 1 HETNAM LEU LEUCINE HETNAM BOG OCTYL BETA-D-GLUCOPYRANOSIDE HETNAM NA SODIUM ION HETSYN BOG BETA-OCTYLGLUCOSIDE; OCTYL BETA-D-GLUCOSIDE; OCTYL D- HETSYN 2 BOG GLUCOSIDE; OCTYL GLUCOSIDE FORMUL 2 LEU C6 H13 N O2 FORMUL 3 BOG 7(C14 H28 O6) FORMUL 10 NA 2(NA 1+) FORMUL 12 HOH *153(H2 O) HELIX 1 1 THR A 10 VAL A 23 1 14 HELIX 2 2 GLY A 24 LEU A 29 1 6 HELIX 3 3 LEU A 29 ASN A 38 1 10 HELIX 4 4 GLY A 40 VAL A 54 1 15 HELIX 5 5 VAL A 54 GLN A 72 1 19 HELIX 6 6 THR A 76 TRP A 85 1 10 HELIX 7 7 ASN A 87 VAL A 95 1 9 HELIX 8 8 VAL A 95 VAL A 124 1 30 HELIX 9 9 ASP A 136 GLY A 153 1 18 HELIX 10 10 SER A 165 ILE A 184 1 20 HELIX 11 11 ARG A 185 GLY A 190 1 6 HELIX 12 12 GLY A 190 LEU A 215 1 26 HELIX 13 13 ALA A 223 THR A 232 1 10 HELIX 14 14 ASP A 234 LEU A 238 5 5 HELIX 15 15 ASP A 240 SER A 256 1 17 HELIX 16 16 GLY A 260 SER A 267 1 8 HELIX 17 17 ILE A 275 ILE A 292 1 18 HELIX 18 18 LEU A 293 GLY A 307 1 15 HELIX 19 19 GLY A 307 GLY A 318 1 12 HELIX 20 20 PHE A 320 ILE A 325 1 6 HELIX 21 21 ILE A 325 SER A 332 1 8 HELIX 22 22 GLY A 336 LEU A 371 1 36 HELIX 23 23 SER A 374 LEU A 396 1 23 HELIX 24 24 LYS A 398 ALA A 407 1 10 HELIX 25 25 THR A 409 TRP A 425 1 17 HELIX 26 26 GLY A 428 ARG A 438 1 11 HELIX 27 27 ARG A 446 TYR A 454 1 9 HELIX 28 28 TYR A 454 TYR A 471 1 18 HELIX 29 29 ILE A 472 GLU A 478 1 7 HELIX 30 30 THR A 482 ALA A 513 1 32 SHEET 1 A 2 GLU A 217 THR A 218 0 SHEET 2 A 2 GLY A 221 THR A 222 -1 O GLY A 221 N THR A 218 CRYST1 89.361 86.664 81.382 90.00 95.94 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011191 0.000000 0.001165 0.00000 SCALE2 0.000000 0.011539 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012354 0.00000